Company Profile

The Gerresheimer Group

Gerresheimer is a leading global partner to the pharma and healthcare industry. With our specialty glass and plastic products, we contribute to health and well-being. We have worldwide operations and about 10,000 employees manufacture our products in local markets, close to our customers. With our plants in Europe, North America, South America and Asia, we generate revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

Revenues by market segment

Consolidated revenues 2017: EUR 1,348.3 Mio.

Gerresheimer - Revenues by market segment

Revenues by region

Gerresheimer - Revenues by economic area

Employees by region

Geresheimer - Employees by region

The Gerresheimer Group had about 10.000 employees as of the end of the financial year 2017.

Our Divisions

Our international business is split into three divisions, to which our individual Group companies are allocated:

Plastics & Devices

The product portfolio of the Plastics & Devices Division includes complex, customer-specific products for the simple and safe administration of medicines, such as insulin pens, inhalers and prefillable syringes. Also included are diagnostics and medical technology products such as lancets and test systems, as well as pharmaceutical plastic containers for liquid and solid medicines with closure and safety systems. For the North American prescription retail market a complete line of regulatory compliant prescription containers for medication dispensing is available.

Primary Packaging Glass

The Primary Packaging Glass Division produces glass primary packaging for medicines and cosmetics, such as pharma jars, ampoules, injection vials, cartridges, perfume flacons and cream jars.

Advanced Technologies

With the acquisition of the Swiss technology company Sensile Medical, we have laid the groundwork for our new division, which will be dedicated to developing and producing intelligent drug delivery systems.

We offer systems like these complete with state-of-the-art digital and electronic technologies to pharmaceutical and biotech companies. Our current portfolio encompasses patented micro pumps for self-treating diabetes or heart disease, for example.

Revenues by division

Consolidated revenues 2017: EUR 1,348.3 Mio.

Gerresheimer - Revenues by division

You can find out more about our product range here.


Contact us!
+49 211 61 81-00